TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/5/23 16:28 | 12/1/23 | IMVT | Immunovant, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Pande Atul | NY | D | S | -491 | 39.73 | 0 | -12 | -11 | 103 | D | |||||||||||||||
2/2/22 16:08 | 2/1/22 | KRTX | Karuna Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Pande Atul | MA | D | S.d | -277 | 110.80 | 0 | -3 | -100 | 0 | D | ||||||||||||||||
1/3/22 19:05 | 1/3/22 | KRTX | Karuna Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Pande Atul | MA | D | S.d | -326 | 130.44 | 0 | -3 | -100 | 0 | D | ||||||||||||||||
12/2/21 17:21 | 12/1/21 | KRTX | Karuna Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Pande Atul | MA | D | S.d | -319 | 127.73 | 0 | -3 | -100 | 0 | D | ||||||||||||||||
11/3/21 16:14 | 11/1/21 | KRTX | Karuna Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Pande Atul | MA | D | S.d | -342 | 136.67 | 0 | -3 | -100 | 0 | D | ||||||||||||||||
10/1/21 16:21 | 10/1/21 | KRTX | Karuna Therapeutics, Inc. | Health | Drug | Pharmaceutical Preparations | Pande Atul | MA | D | S.d | -302 | 120.72 | 0 | -3 | -100 | 0 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |